Abstract
Purpose
To investigate the presence of pachychoroid spectrum disease (PSD) in patients with Cushing disease (CD) and to evaluate subfoveal choroidal thickness (SFCT) and choriocapillary flow using spectral domain OCT (SD-OCT) with the enhanced depth imaging (EDI) and optical coherence tomography angiography (OCT-A).
Methods
Thirty-two patients with CD and 32 age- and sex-matched healthy volunteers were enrolled in this observational study. All participants had a complete ophthalmic examination including SD-OCT with EDI and OCT-A, and were subjected to the Perceived Stress Scale test (PSS). All patients with CD had hormone test including 24-h urinary-free cortisol (UFC) and plasma adrenocorticotropic hormone (ACTH). We compared SFCT and choriocapillary vessel density (CVD) between the two groups and evaluated the presence of PSD. We investigated the association of hormone level, SFTC, CVD with the presence of CD; the association between the hormone level, SFTC, CVD, the CD disease activity, and duration with the presence of PSD in CD patients; and the association between SFTC and CVD with the hormone level, the CD disease activity, and duration in CD patients.
Results
Higher values of SFCT and CVD were associated with CD (β: 0.028, 95% CI: 0.014; 0.041; β: 0.912, 95%CI: 0.205; 1.62, respectively). Twelve patients with CD (37.5%) reported a PSD in at least one eye, whereas no subject was found in control group (p < 0.001); in particular, 11 CD patients (34%) presented pachychoroid pigment epitheliopathy (PPE) and 1 CD patient (3%) presented polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV/AT1). In patients with CD, a significant positive association between SFCT and PSD was found (β: 0.010, 95% CI 0.001; 0.019).
Conclusion
A chronic state of hypercortisolism may have direct implications on the choroid. Patients with CD had higher SFCT values and a significant change in the choriocapillary flow compared to healthy controls. Moreover, PSD was observed only in CD patients.
Similar content being viewed by others
References
Warrow DJ, Hoang QV, Freund KB (2013) Pachychoroid pigment epitheliopathy. Retina 33(8):1659–1672
Cheung CMG, Lee WK, Koizumi H et al (2019) Pachychoroid disease. Eye 33(1):14–33
Bin WW, Xu L, Jonas JB et al (2013) Subfoveal choroidal thickness: the Beijing eye study. Ophthalmology 120(1):175–180
Mrejen S, Spaide RF (2013) Optical coherence tomography: imaging of the choroid and beyond. Surv Ophthalmol 58(5):387–429
Haimovici R, Rumelt S, Melby J (2003) Endocrine abnormalities in patients with central serous chorioretinopathy. Ophthalmology 110(4):698–703
Garg SP, Dada T, Talwar D, Biswas NR (1997) Endogenous cortisol profile in patients with central serous chorioretinopathy. Br J Ophthalmol 81(11):962–964. https://doi.org/10.1136/bjo.81.11.962
Bouzas EA, Karadimas P, Pournaras CJ (2002) Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol 47(5):431–448
Zhao M, Célérier I, Bousquet E et al (2012) Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy. J Clin Invest 122(7):2672–2679
Bousquet E, Beydoun T, Zhao M et al (2013) Mineralocorticoid receptor antagonism in the treatment of chronic central serous chorioretinopathy: a pilot study. Retina 33(10):2096–2102
Daruich A, Matet A, Dirani A et al (2015) Central serous chorioretinopathy: recent findings and new physiopathology hypothesis. Prog Retin Eye Res 48:82–118
Abalem MF, Machado MC, Veloso Dos Santos HN et al (2016) Choroidal and retinal abnormalities by optical coherence tomography in endogenous Cushing’s syndrome. Front Endocrinol 7:154
Karaca C, Karaca Z, Kahraman N et al (2017) Is there a role of acth in increased choroidal thickness in cushing syndrome? Retina 37(3):536–543
Wang E, Chen S, Yang H et al (2019) Choroidal thickening and pachychoroid in cushing syndrome: correlation with endogenous cortisol level. Retina 39(2):408–414
Eymard P, Gerardy M, Bouys L et al (2021) Choroidal imaging in patients with Cushing syndrome. Acta Ophthalmol 99(5):533–537
Cushing H (1994) The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism) 1932. Obes Res 2(5):486–508
Öner A, Deliktas G, Arda H et al (2014) Diurnal variation of central choroidal thickness in healthy Turkish subjects measured by spectral-domain optical coherence tomography. Retina-Vitreus 22(3):204–208
Nieman LK, Biller BMK, Findling JW et al (2008) The diagnosis of Cushing’s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(5):1526–1540
Vallejo MA, Vallejo-Slocker L, Fernández-Abascal EG, Mañanes G (2018) Determining factors for stress perception assessed with the Perceived Stress Scale (PSS-4) in Spanish and other European samples. Front Psychol 9:37
Bouzas EA, Scott MH, Mastorakos G et al (1993) Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol 111(9):1229–1233
Giovansili I, Belange G, Affortit A (2013) Cushing disease revealed by bilateral atypical central serous chorioretinopathy: case report. Endocr Pract 19(5):e129-33
Yannuzzi LA (2012) Type A behavior and central serous chorioretinopathy. Retina 32(Suppl 1):709
Williams RB, Lane JD, Kuhn CM et al (1982) Type A behavior and elevated physiological and neuroendocrine responses to cognitive tasks. Science (80- ) 218(4571):483–485
Siedlecki J, Schworm B, Priglinger SG (2019) The pachychoroid disease spectrum-and the need for a uniform classification system. Ophthalmol Retin 3(12):1013–1015
Dansingani KK, Balaratnasingam C, Naysan J, Freund KB (2016) En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina 36(3):499–516
Dansingani KK, Balaratnasingam C, Klufas MA et al (2015) Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol 160(6):1243-1254.e2
Gal-Or O, Dansingani KK, Sebrow D et al (2018) Inner choroidal flow signal attenuation in pachychoroid disease: Optical coherence tomography angiography. Retina 38(10):1984–1992
Baek J, Kook L, Lee WK (2019) Choriocapillaris flow impairments in association with pachyvessel in early stages of pachychoroid. Sci Rep 9(1):5565
Teussink MM, Breukink MB, Van Grinsven MJJP et al (2015) Oct angiography compared to fluorescein and indocyanine green angiography in chronic central serous chorioretinopathy. Investig Ophthalmol Vis Sci 56(9):5229–5237
Akkaya S (2018) Spectrum of pachychoroid diseases. Int Ophthalmol 38(5):2239–2246
Demirel S, Değirmenci MFK, Batıoğlu F, Özmert E (2021) Evaluation of the choroidal features in pachychoroid spectrum diseases by optical coherence tomography and optical coherence tomography angiography. Eur J Ophthalmol 31(1):184–193
Author information
Authors and Affiliations
Contributions
Nicola Vito Lassandro was involved in the study conception and design. Material preparation, data collection, and analysis were performed by Nicola Vito Lassandro, Michele Nicolai, Luca Cantini, Alessandro Franceschi, Rosaria Gesuita, and Andrea Faragalli. The first draft of the manuscript was written by Nicola Vito Lassandro and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study protocol was approved by the Ospedali Riuniti of Ancona Local Scientific committee.
Consent to participate
Informed consent was obtained from all individual participants included in the study.
Consent to publish
Patients signed informed consent regarding publishing their data and photographs.
Conflict of interest
The authors declare no competing interests.
Disclaimer
The principal investigator, Dr. Lassandro Nicola Vito had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the analysis.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lassandro, N.V., Nicolai, M., Arnaldi, G. et al. Pachychoroid spectrum disease and choriocapillary flow analysis in patients with Cushing disease: an optical coherence tomography angiography study. Graefes Arch Clin Exp Ophthalmol 260, 1535–1542 (2022). https://doi.org/10.1007/s00417-021-05524-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-021-05524-2